Black Diamond Therapeutics Inc (BDTX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Black Diamond Therapeutics Inc   (NASDAQ: BDTX)


Black Diamond Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Black Diamond Therapeutics Inc's ROI in the second quarter of 2026?
Black Diamond Therapeutics Inc recorded a cumulative net loss of $-43 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -34.25%.

Within the Healthcare sector 394 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3434 to 3519.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -5.89 % 5.36 % 21.43 % 7.79 % -4.57 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 109 118 127 142 150
Return On Investment (TTM) -34.25 % -32.16 % 15.47 % 15.54 % 10.94 %
BDTX's Overall Ranking # 3519 # 3434 # 393 # 403 # 552
Seq. Investment Change TTM -7.52 % -7.09 % 4.56 % 4.75 % 3.54 %
Seq. Net Income Change TTM - - 4.04 % 48.89 % 183.62 %
Net Income (TTM) in Millions -43 -43 22 21 14

BDTX Company Profile >> Back to BDTX Roi Comparisons >> See Annual BDTX Return On Investment



Return On Investment BDTX's Ranking
Within: No.
Industry # 47
Sector # 395
Overall # 3519

Return On Investment Statistics
High Average Low
398.87 %
-13.89 %
-63.84 %
(Dec 31 2019)   (Sep 30 2023)







Financial Statements
Black Diamond Therapeutics Inc's II. Quarter Investments $ 109 Millions BDTX's Balance sheet
Black Diamond Therapeutics Inc's II. Quarter Income $ -10 Millions Quarterly BDTX's Income Statement
BDTX's Income by Division See BDTX's Income by Division


BDTX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 127 102 139 141 224
Y / Y Investment Growth 24.7 % -26.53 % -1.47 % -37.07 % -28.98 %
Net Income in Millions 22 -70 -82 -91 -126
Y / Y Net Income Growth - - - - -
Annual Return On Investment 17.57 % -68.26 % -59.34 % -64.66 % -56.06 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 17.57 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BDTX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BDTX's Competitors
Subscribers only: Roi for Black Diamond Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for BDTX's Customers

Other Ratios
BDTX's Roa BDTX's Inventory Turnover Ratio BDTX's Growth Rates BDTX's Dividend Statistics
BDTX's Profitability Ratios BDTX's Asset Turnover Ratio BDTX's Dividend Growth
BDTX's Roe BDTX's Valuation Ratios BDTX's Financial Strength Ratios BDTX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-09T01:59:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.